These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 9381564)

  • 1. [How to increase patient compliance? Report and discussion on a Cochrane analysis].
    Olesen F; Lous J
    Ugeskr Laeger; 1997 Sep; 159(40):5929-32. PubMed ID: 9381564
    [No Abstract]   [Full Text] [Related]  

  • 2. Discussion of "Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data".
    Small DS; Cheng J
    Biometrics; 2009 Sep; 65(3):682-6; discussion 689-91. PubMed ID: 18759846
    [No Abstract]   [Full Text] [Related]  

  • 3. The compliance score as a regressor in randomized trials.
    Joffe MM; Ten Have TR; Brensinger C
    Biostatistics; 2003 Jul; 4(3):327-40. PubMed ID: 12925501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D; Kim MY
    Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cochrane group for anesthesia].
    Møller AM; Pedersen T; Bismuth L
    Ugeskr Laeger; 2000 Jul; 162(27):3868-9. PubMed ID: 10920705
    [No Abstract]   [Full Text] [Related]  

  • 6. Older adult medication compliance: integrated review of randomized controlled trials.
    Russell CL; Conn VS; Jantarakupt P
    Am J Health Behav; 2006; 30(6):636-50. PubMed ID: 17096621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized consent designs in randomized controlled trials: systematic literature search.
    Schellings R; Kessels AG; ter Riet G; Knottnerus JA; Sturmans F
    Contemp Clin Trials; 2006 Aug; 27(4):320-32. PubMed ID: 16388991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Cochrane Hepato-Biliary Group--status after three years].
    Gluud CN; Jørgensen T
    Ugeskr Laeger; 2000 May; 162(21):3017-9. PubMed ID: 10850188
    [No Abstract]   [Full Text] [Related]  

  • 9. On estimating treatment effects under non-compliance in randomized clinical trials: are intent-to-treat or instrumental variables analyses perfect solutions?
    Bang H; Davis CE
    Stat Med; 2007 Feb; 26(5):954-64. PubMed ID: 16900559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A note on 'The method of handling non-compliance in clinical trials suggested by Sato/Matsuyama'.
    Sjölander A
    Stat Med; 2008 Aug; 27(19):3920-4. PubMed ID: 18407577
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ethic problems of randomized trials].
    Vlasov VV
    Ter Arkh; 2000; 72(2):78-80. PubMed ID: 10717937
    [No Abstract]   [Full Text] [Related]  

  • 12. Principal stratification with predictors of compliance for randomized trials with 2 active treatments.
    Roy J; Hogan JW; Marcus BH
    Biostatistics; 2008 Apr; 9(2):277-89. PubMed ID: 17681993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [National crisis discussion necessary: 2 million hypertensive patients dropped out?].
    Aumiller J
    MMW Fortschr Med; 2005 Jan; 147(3):4-6, 8, 10. PubMed ID: 15727100
    [No Abstract]   [Full Text] [Related]  

  • 14. Weighting in instrumental variables and G-estimation.
    Joffe MM; Brensinger C
    Stat Med; 2003 Apr; 22(8):1285-303. PubMed ID: 12687655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments on 'On estimating treatment effects under non-compliance in randomized clinical trials: are intent-to-treat or instrumental variables analyses perfect solutions?' by Heejung Bang and Clarence E. Davis, Statistics in Medicine 2007; 26:954-964.
    Lui KJ
    Stat Med; 2009 Feb; 28(3):531-4. PubMed ID: 19125394
    [No Abstract]   [Full Text] [Related]  

  • 16. Intention-to-treat analysis: protecting the integrity of randomization.
    Mahaniah KJ; Rao G
    J Fam Pract; 2004 Aug; 53(8):644. PubMed ID: 15298838
    [No Abstract]   [Full Text] [Related]  

  • 17. [Randomized controlled trials: a controversial past and a future of regulation and rejection].
    Strippoli GF; Manno C; Schena FP
    G Ital Nefrol; 2002; 19(1):4-12. PubMed ID: 12165939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interventions to improve the management of diabetes mellitus in primary health care and outpatient community settings].
    Hansen LJ; Drivsholm TB
    Ugeskr Laeger; 2002 Jan; 164(5):607-9. PubMed ID: 11871208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How can the results of primary-care treatment for depression be improved?].
    Vergouwen AC; Burger H; Verheij TJ; Koerselman GF
    Tijdschr Psychiatr; 2007; 49(8):559-67. PubMed ID: 17694489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.
    Jo B
    Stat Med; 2002 Nov; 21(21):3161-81. PubMed ID: 12375297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.